Dittrich, C., Fridrik, M. A., Koenigsberg, R., Lee, C., Goeldner, R., Hilbert, J., & Greil, R. (2014). A phase 1 dose escalation study of BI 831266, an inhibitor of Aurora kinase B, in patients with advanced solid tumors. Invest New Drugs.

Dittrich, Christian, Michael A. Fridrik, Robert Koenigsberg, Chooi Lee, Rainer-Georg Goeldner, James Hilbert, and Richard Greil. "A Phase 1 Dose Escalation Study of BI 831266, an Inhibitor of Aurora Kinase B, in Patients With Advanced Solid Tumors." Invest New Drugs 2014.

Dittrich, Christian, et al. "A Phase 1 Dose Escalation Study of BI 831266, an Inhibitor of Aurora Kinase B, in Patients With Advanced Solid Tumors." Invest New Drugs 2014.